NFKB1 and breast cancer: The present investigation was conducted to determine the percentage of MCF-7 and MDA-MB-231 breast cancer cells with an active form of NF-κB protein after 24 h of exposure to the tested compounds (EDA-71 and cisplatin) at concentrations of 1.5 and 3 μM.